Population
Healthy controls and end-stage chronic renal failure patients
Design
Other
Authors
Loading...
ADMA elevation in renal failure may inform cardiovascular risk assessment; leaves open clinical adoption pending prospective validation.
A robust liquid chromatography/mass spectrometry method utilizing isotope dilution accurately measures ARG and ADMA in human plasma, demonstrating significantly elevated ADMA and reduced ARG in end-stage chronic renal failure patients.
Martens‐Lobenhoffer et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: